1. Successful treatment of a locally advanced unresectable pancreatic cancer patient with interstitial pneumonitis by conversion surgery following gemcitabine plus nab‑paclitaxel chemotherapy: A case report
   Tetsuo Yokota et al, 2019, Molecular and Clinical Oncology CrossRef
2. Comprehensive analysis of the expression and prognosis for RBR E3 ubiquitin ligases in lung adenocarcinoma
   Hao Ding et al, 2022, Thoracic Cancer CrossRef
3. Interstitial lung disease associated with nanoparticle albumin-bound paclitaxel treatment in patients with lung cancer
   Takeru Kashiwada et al, 2019, Japanese Journal of Clinical Oncology CrossRef
4. Incidence and appropriate management of drug‐induced interstitial lung disease in Japanese patients with unresectable pancreatic cancer: A multicenter retrospective study
   Tsukasa Miyagahara et al, 2023, Asia-Pacific Journal of Clinical Oncology CrossRef
5. Identification of an early diagnostic biomarker of lung adenocarcinoma based on co-expression similarity and construction of a diagnostic model
   Zhirui Fan et al, 2018, Journal of Translational Medicine CrossRef
6. Nanoparticle albumin bound-paclitaxel for treatment of advanced non-small cell lung cancer: an evaluation of the clinical evidence
   Diego Adrianzen Herrera et al, 2019, Expert Opinion on Pharmacotherapy CrossRef
7. Interstitial lung disease in advanced pancreatic ductal adenocarcinoma patients treated with gemcitabine and nab-paclitaxel combination therapy: a retrospective analysis
   Hiroki Irie et al, 2020, Cancer Chemotherapy and Pharmacology CrossRef